Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C

Full text
Author(s):
Neres-Santos, Raquel Silva [1] ; Junho, Carolina Victoria Cruz [1] ; Panico, Karine [1] ; Caio-Silva, Wellington [1] ; Pieretti, Joana Claudio [2] ; Tamashiro, Juliana Almeida [1] ; Seabra, Amedea Barozzi [2] ; Ribeiro, Cesar Augusto Joao [3] ; Carneiro-Ramos, Marcela Sorelli [1]
Total Authors: 9
Affiliation:
[1] Fed Univ ABC, Ctr Nat & Human Sci CCNH, Lab Cardiovasc Immunol, BR-09210580 Santo Andre, SP - Brazil
[2] Fed Univ ABC, Ctr Nat & Human Sci CCNH, Lab BioNanoMet, BR-09210580 Santo Andre, SP - Brazil
[3] Fed Univ ABC, Ctr Nat & Human Sci CCNH, BR-09210580 Santo Andre, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: CELLS; v. 10, n. 11 NOV 2021.
Web of Science Citations: 0
Abstract

Cardiorenal syndrome (CRS) is a pathological link between the kidneys and heart, in which an insult in a kidney or heart leads the other organ to incur damage. CRS is classified into five subtypes, and type 3 (CRS3) is characterized by acute kidney injury as a precursor to subsequent cardiovascular changes. Mitochondrial dysfunction and oxidative and nitrosative stress have been reported in the pathophysiology of CRS3. It is known that vitamin C, an antioxidant, has proven protective capacity for cardiac, renal, and vascular endothelial tissues. Therefore, the present study aimed to assess whether vitamin C provides protection to heart and the kidneys in an in vivo CRS3 model. The unilateral renal ischemia and reperfusion (IR) protocol was performed for 60 min in the left kidney of adult mice, with and without vitamin C treatment, immediately after IR or 15 days after IR. Kidneys and hearts were subsequently collected, and the following analyses were conducted: renal morphometric evaluation, serum urea and creatinine levels, high-resolution respirometry, amperometry technique for NO measurement, gene expression of mitochondrial dynamic markers, and NOS. The analyses showed that the left kidney weight was reduced, urea and creatinine levels were increased, mitochondrial oxygen consumption was reduced, NO levels were elevated, and Mfn2 expression was reduced after 15 days of IR compared to the sham group. Oxygen consumption and NO levels in the heart were also reduced. The treatment with vitamin C preserved the left kidney weight, restored renal function, reduced NO levels, decreased iNOS expression, elevated constitutive NOS isoforms, and improved oxygen consumption. In the heart, oxygen consumption and NO levels were improved after vitamin C treatment, whereas the three NOS isoforms were overexpressed. These data indicate that vitamin C provides protection to the kidneys and some beneficial effects to the heart after IR, indicating it may be a preventive approach against cardiorenal insults. (AU)

FAPESP's process: 15/25541-0 - Investigation of the mechanisms of toxicity in methylmalonic academia - evaluation of cell bioenergetics, oxidative stress, signaling pathways and potential strategies of protection
Grantee:César Augusto João Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 18/08194-2 - Essential oil amended with metal nanoparticles functionalized with nitric oxide as a strategy to control plant pathogens in the agriculture
Grantee:Amedea Barozzi Seabra
Support Opportunities: Regular Research Grants
FAPESP's process: 19/11077-0 - Cardiac alterations induced by renal inflammation models: participation of the Klotho/FGF-23 axis
Grantee:Marcela Sorelli Carneiro Ramos
Support Opportunities: Regular Research Grants
FAPESP's process: 20/03646-2 - Impact of nanoplatforms allied to nitric oxide and chemotherapeutics on cytotoxicity and sensitization of resistant tumor cells
Grantee:Joana Claudio Pieretti
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/19107-5 - TLR4 and complement system : possible key mechanism in renal ischemia/reperfusion induced cardiac hypertrophy
Grantee:Marcela Sorelli Carneiro Ramos
Support Opportunities: Regular Research Grants